Summary by Moomoo AI
On January 10, 2024, Arundathy N. Pandite, the Chief Medical Officer of Shattuck Labs, Inc., completed a series of transactions involving the company's common stock. Pandite acquired 46,475 shares at no cost, which is typically indicative of a grant or award. On the same day, she disposed of 2,987 shares at a price of $10.09 per share, a transaction often associated with the payment of exercise price or tax liability by delivering or withholding securities. Following these transactions, Pandite's direct holdings in Shattuck Labs totaled 219,280 shares. The total market value of the disposed shares amounted to $30,138.83.